Last reviewed · How we verify
Placebo (for Pregabalin)
A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.
A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect. Used for Control arm in Pregabalin clinical trials.
At a glance
| Generic name | Placebo (for Pregabalin) |
|---|---|
| Also known as | Sugar pill manufactured to mimic Pregabalin 150 mg tablet, Sugar pill manufactured to mimic Pregabalin 300 mg tablet |
| Sponsor | Eastern Hepatobiliary Surgery Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebos are inert substances used as controls in clinical trials to measure the effect of expectation and psychological factors on patient outcomes. In this context, it serves as a comparator arm in trials evaluating Pregabalin efficacy. Any observed clinical benefit from placebo administration results from patient expectation, conditioning, and natural disease course rather than pharmacological action.
Approved indications
- Control arm in Pregabalin clinical trials
Common side effects
- Placebo effect (perceived symptom improvement)
Key clinical trials
- Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia (NA)
- Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy (PHASE2)
- Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver (PHASE4)
- Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome (NA)
- Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal (PHASE2)
- Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy (PHASE3)
- Oral Melatonin Versus Oral Pregabalin on Postoperative Pain and Anxiety Following Spine Surgery (NA)
- Adding Amantadine to Pregabalin on Occurrence of Post-thoracotomy Pain Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (for Pregabalin) CI brief — competitive landscape report
- Placebo (for Pregabalin) updates RSS · CI watch RSS
- Eastern Hepatobiliary Surgery Hospital portfolio CI